Nanxin Pharmaceutical announced that Guangzhou Qianyuan plans to reduce its shareholding by no more than 2%.
南新制药：广州乾元拟减持股份不超过2%
Nanxin Pharmaceutical: Guangzhou Qianyuan plans to reduce its shareholding by no more than 2%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.